Tsirogianni, M. Grigoriou, E. Kapsimalli, V. Dagla, K. Stamouli, M. Gkirkas, K. Konsta, E. Karagiannidou, A. Gkodopoulos, K. Stavroulaki, G. Pappa, V. Angelopoulou, M. Lowdell, M. Tsirigotis, P., Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine, Clinical Lymphoma Myeloma and Leukemia, (60), 2457-2463, 2019, Taylor and Francis Ltd.,